Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ERIC 2022 | COVID-19 infection in patients with CLL

Antonio Cuneo • 7 Oct 2022
ERIC 2022
Chronic Lymphocytic Leukemia Leukemia

Antonio Cuneo, MD, St. Anna University Hospital, Ferrara, Italy, comments on the risk of developing severe COVID-19 infection in patients with chronic lymphocytic leukemia (CLL). Dr Cuneo explains that COVID-19 infection can lead to pneumonia, bacterial infection, and deterioration of the clinical status in patients with CLL, and it is therefore essential for these patients to be appropriately treated as early as possible. This interview took place at the 2022 European Research Initiative on CLL (ERIC) Meeting.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Antonio Cuneo

2:18
Tools to improve the outcomes of patients with CLL affected by COVID-19
Antonio Cuneo • 7 Oct 2022
1:25
The management of CLL in Italy
Antonio Cuneo • 7 Oct 2022
1:09
The impact of complex karyotype on treatment efficacy and prognosis in CLL
Antonio Cuneo • 7 Oct 2022
1:45
The importance of real-world data in CLL & efficacy of BTK and Bcl-2 inhibitors in the real world
Antonio Cuneo • 7 Oct 2022

Related Videos

1:17
The curative potential of alloSCT in the treatment of HR-MDS
Jurjen Versluis • 22 Apr 2024
10:34
Remission induction therapy prior to alloSCT in AML: insights from the ASAP trial
Johannes Schetelig • 19 Apr 2024
1:57
The FORUM trials: results of F1 and plans for F2
Christina Peters • 15 Apr 2024
5:28
Young matched unrelated donors versus older-aged matched sibling donors in alloSCT with PTCy
Karthik Nath • 17 Apr 2024
The content of VJHemOnc is intended for healthcare professionals